Noteworthy Tuesday Option Activity: LMND, CWAN, DAVE

Unusually large options volume has concentrated in calls for Clearwater Analytics (CWAN) and Dave Inc (DAVE) today: CWAN saw 81,855 contracts (≈8.2M underlying shares), about 44.9% of its one‑month ADV (18.2M), led by 69,296 contracts in the $25 call expiring March 20, 2026 (~6.9M shares). DAVE recorded 2,022 contracts (≈202,200 shares), ~42.4% of its one‑month ADV (476,395), with 954 contracts in the $190 call expiring Feb 20, 2026 (~95,400 shares). The concentrated call activity signals significant bullish/options‑driven positioning that could create intraday directional pressure on the two names and merits monitoring by liquidity and flow desks.

Analysis

Market structure: Large call prints in CWAN (69,296 contracts ≈6.9M shares, ~44.9% of 1‑month ADV) and concentrated DAVE activity (954 contracts ≈95.4k shares, ~42% of ADV) signal outsized demand for upside exposure in otherwise thinly traded names. Immediate beneficiaries include call buyers and market makers (via premium), while uncovered short sellers could be forced to cover if delta-hedging by market makers creates a feedback loop. The flow is idiosyncratic — it won’t move macro bond/FX/commodity markets materially but can meaningfully distort small‑cap liquidity and implied volatility for these tickers and related ETFs for days–weeks.

Risk assessment: Tail risks include the trade being a large sell (block write) or part of a synthetic position, regulatory scrutiny/insider activity, or a liquidity squeeze that reverses violently; quantify: a sustained 20–50% IV move would severely widen spreads and margin demands. Time horizons: expect gamma-driven price moves over days–weeks, directional realization through Mar/Feb 2026 expiries, and structural re-rating only if corporate catalysts (earnings/M&A/index inclusion) materialize over months. Hidden dependencies include open interest, short interest and market‑maker delta hedges which could amplify moves; key catalysts are earnings, filings, or a large buyer unwinding within 30–90 days.

Trade implications: For CWAN prefer directional but defined-risk exposure: call-spreads (Mar 20, 2026 25/30) or small equity sized 1–2% of portfolio to capture upside from implied‑volatility expansion and delta flow; trim if CWAN rallies >30% or IV >+50% from current. For DAVE, treat as speculative: cap exposure to 0.25–0.5% via tight call spreads into Feb 20, 2026 and avoid levering given high strike and lower liquidity. Consider relative-value: long CWAN / short IWM (or small‑cap ETF) to isolate idiosyncratic upside while hedging beta over 1–3 months.

Contrarian angles: The market often misreads heavy call volume as pure bullish intent — it can be a dealer‑sell, arb play, or synthetic short; if IV spikes >40% without fundamental change the tactical trade is to sell premium (calendar or iron‑condor) sized to 0.5–1% for 30–60 day horizons. Historical analogs show concentrated call prints in small caps can precede short squeezes or quick fadeouts; watch for regulatory filings or block trade reports within 7 trading days as a sanity check before scaling positions.

Key Decisions for Investors

• Establish a 1–2% long-equity position in CWAN within 3 trading days OR buy a Mar 20, 2026 25/30 call debit spread sized to 0.5–1% of portfolio; stop-loss: cut if CWAN price drops 15% from entry or if implied volatility falls >30% from current levels.
• Open a speculative 0.25–0.5% position in DAVE via a Feb 20, 2026 190/210 call spread (debit) to limit downside; exit if no ≥40% notional appreciation within 30 calendar days or if IV rises >50% (indicating premium exhaustion or dealer unwind).